Vanda Pharmaceuticals News

VNDA Rejects Second Takeover Bid by Cycle Group, Stock Rises

Zacks Oct 15 11:05 ET

Cycle Pharmaceuticals Reaffirms Proposal to Acquire Vanda Pharmaceuticals

Yahoo FinanceOct 15 08:30 ET

Sector Update: Health Care Stocks Higher Monday Afternoon

MT NewswiresOct 14 13:50 ET

Vanda Pharmaceuticals Shares Rise; Cycle Pharmaceuticals' Buyout Offer Rejected Again

MT NewswiresOct 14 11:55 ET

Vanda Pharmaceuticals: Cycle Offer 'Substantially Undervalues' Vanda

TipRanksOct 14 11:00 ET

Express News | Vanda Pharmaceuticals Inc - Board Has Determined That Latest Proposal Is Not in Best Interests of Company or Stockholders

ReutersOct 14 10:56 ET

Express News | Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal From Cycle Group Holdings Ltd.

ReutersOct 14 10:56 ET

Press Release: Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal From Cycle Group Holdings Ltd.

Dow JonesOct 14 10:56 ET

Vanda Pharma Soars as Cycle Pharma Reiterates $8/share Offer

Seeking AlphaOct 14 08:46 ET

Express News | Cycle Pharmaceuticals: Ready to Work Immediately With Vanda's Board, Management to Reach Agreement

ReutersOct 14 08:22 ET

Express News | Cycle Pharmaceuticals: Vanda's Board and Management Team Have Refused to Engage With US

ReutersOct 14 08:21 ET

Cycle Pharmaceuticals Reaffirms Proposal To Acquire Vanda Pharmaceuticals For $8.00 Per Share In Cash

BenzingaOct 14 08:20 ET

Express News | Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 per Share

ReutersOct 14 08:19 ET

Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share

BusinesswireOct 14 08:19 ET

Evoke Pharma Reaffirms Its Commitment To Improving The Lives Of Patients Suffering From Diabetic Gastroparesis In Light Of The Recent Decision By The U.S. FDA To Not Approve Vanda Pharmaceuticals NDA For Tradipitant, An Oral Drug Candidate For The...

BenzingaSep 19 14:23 ET

4 Stocks to Watch on Thursday: DRI, FDX and More

Seeking AlphaSep 19 09:08 ET

Vanda Pharma Shares Fall 15% as FDA Denies Approval of Tradipitant NDA for Treating Gastroparesis Symptoms

MT NewswiresSep 19 08:26 ET

Vanda Slips as FDA Rejects Therapy for Stomach Condition

Seeking AlphaSep 19 07:54 ET

Top Premarket Decliners

MT NewswiresSep 19 07:52 ET

Why Is Vanda Pharmaceuticals Stock Falling In Pre-market?

RTTNewsSep 19 07:34 ET